feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Orry summoned in drugs case

trending

Nvidia Q3 earnings preview

trending

Manika Vishwakarma shines at Miss Universe

trending

Mt. Gox moves Bitcoin

trending

Nasdaq futures rebound: Nvidia earnings

trending

Infosys buyback strengthens shareholder value

trending

Adani acquires Jaiprakash Associates

trending

Excelsoft Technologies IPO oversubscribed

trending

Sonam Kapoor announces pregnancy

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Brain Cancer Drug Given Years Too Long, Ruining Lives

Brain Cancer Drug Given Years Too Long, Ruining Lives

19 Nov

•

Summary

  • Patients received excessive chemotherapy drugs for two decades.
  • Overdosing left patients housebound with severe side effects.
  • Legal action is being prepared against the hospital trust.
Brain Cancer Drug Given Years Too Long, Ruining Lives

Dozens of patients allege their lives were severely impacted by prolonged and unnecessary chemotherapy treatments administered over two decades at the University Hospitals Coventry and Warwickshire NHS Trust. Gayle Bodinnar, diagnosed with a brain tumor, received over 150 cycles of the drug temozolomide, significantly exceeding the recommended six-month NHS protocol.

This excessive treatment resulted in debilitating side effects for Ms. Bodinnar, including chronic fatigue, memory issues, and becoming housebound for life. Many other patients reported similar consequences, such as extreme exhaustion, sickness, seizures, and secondary cancers, with some facing ruined careers.

Legal action is now being prepared against the trust, with patients demanding an independent investigation into the treatments provided. Lawyers are calling for a review dating back to 2006, encompassing multiple clinicians and pharmacists involved in the repeated prescribing of the drug.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Temozolomide is a powerful chemotherapy drug for brain tumors. Patients allege it was given for years beyond the recommended six months without proper consent or clinical trial documentation.
Patients reported devastating side effects including extreme fatigue, confusion, memory loss, sickness, seizures, and in some cases, secondary cancers, leading to a severely diminished quality of life.
Yes, over 30 patients are preparing legal action against the trust, seeking answers and accountability for the prolonged and allegedly unnecessary chemotherapy treatments.

Read more news on

Healthside-arrow

You may also like

Boy's Mouth Sealed Shut After Drinking Drain Cleaner

17 hours ago • 4 reads

article image

NHS Maintains 95% Operations Despite Resident Doctors' Strike

17 Nov • 10 reads

article image

AI to Assist UK Hospitals in Faster Fracture Detection

17 Nov • 12 reads

article image

Woman Describes "Agonizing" Hysteroscopy Without Consent

17 Nov • 11 reads

article image

Hospitals Grapple with Medically Fit Patients Occupying Beds

16 Nov • 15 reads

article image